ConductScience.org, home

Comparison · NCT03389620-deaths

Transforaminal Cervical Epidural Corticosteroid Injections vs Lateralized Interlaminar Epidural Corticosteroid Injections: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Transforaminal Cervical Epidural Corticosteroid Injections vs Lateralized Interlaminar Epidural Corticosteroid Injections: deaths from any cause. Trial comparisons, record NCT03389620-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03389620-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 1000.0941wilson
Risk in group 2000.0941wilson
Risk difference, group 1 minus group 20-0.09410.0941newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to harmfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Transforaminal Cervical Epidural Corticosteroid Injectionsdexamethasone: 0.8 mL of dexamethasone (10 mg/mL) will slowly be injected over a period of approximately 30 seconds037EG000
Group 2Lateralized Interlaminar Epidural Corticosteroid Injectionsdexamethasone: 0.8 mL of dexamethasone (10 mg/mL) will slowly be injected over a period of approximately 30 seconds037EG001

Harm

What it counts
Total, all-cause mortality
Time frame
Up to 2 days post-procedure

Source ClinicalTrials.gov

Trial

Title
Transforaminal Versus Lateralized Interlaminar Cervical Epidurals
NCT number
NCT03389620
Phases
PHASE2
Conditions
Cervicogenic Upper Extremity Radiculopathy
Interventions
dexamethasone
Lead sponsor
Duke University
Results first posted
2025-12-19

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03389620-deaths